INCYTE CORPORATION Selling, General and Administrative Expense
INCYTE CORPORATION (INCY) reported Selling, General and Administrative Expense of $328.09 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-04-28
- INCYTE CORPORATION selling, general and administrative expense for the quarter ending 2026-03-31 was $328.09M, a 0.74% increase year-over-year.
- INCYTE CORPORATION selling, general and administrative expense for the quarter ending 2025-12-31 was $390.41M, a 19.50% increase year-over-year.
- INCYTE CORPORATION selling, general and administrative expense for the quarter ending 2025-09-30 was $329.08M, a 6.43% increase year-over-year.
- INCYTE CORPORATION selling, general and administrative expense for the quarter ending 2025-06-30 was $331.02M, a 8.18% increase year-over-year.
- INCYTE CORPORATION selling, general and administrative expense for fiscal 2025 was $1.38B, a 10.79% increase from fiscal 2024.
- INCYTE CORPORATION selling, general and administrative expense for fiscal 2024 was $1.24B, a 7.48% increase from fiscal 2023.
- INCYTE CORPORATION selling, general and administrative expense for fiscal 2023 was $1.16B, a 15.32% increase from fiscal 2022.
- INCYTE CORPORATION selling, general and administrative expense for fiscal 2022 was $1.00B, a 35.50% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $328.09M 10-Q · filed 2026-04-28 | $718.50M derived: sum of 2 quarters · filed 2026-04-28 | $1.05B derived: sum of 3 quarters · filed 2026-04-28 | $1.38B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-12-31 | $390.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $719.49M derived: sum of 2 quarters · filed 2026-02-10 | $1.05B derived: sum of 3 quarters · filed 2026-02-10 | $1.38B 10-K · filed 2026-02-10 | ||||
| 2025-09-30 | $329.08M 10-Q · filed 2025-10-28 | $660.10M derived: sum of 2 quarters · filed 2025-10-28 | $985.79M 10-Q · filed 2025-10-28 | $1.31B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-06-30 | $331.02M 10-Q · filed 2025-07-29 | $656.71M 10-Q · filed 2025-07-29 | $983.42M derived: sum of 3 quarters · filed 2026-04-28 | $1.29B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2025-03-31 | $325.69M 10-Q · filed 2026-04-28 | $652.40M derived: sum of 2 quarters · filed 2026-04-28 | $961.61M derived: sum of 3 quarters · filed 2026-04-28 | $1.27B derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | $326.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $635.92M derived: sum of 2 quarters · filed 2026-02-10 | $941.90M derived: sum of 3 quarters · filed 2026-02-10 | $1.24B 10-K · filed 2026-02-10 | ||||
| 2024-09-30 | $309.21M 10-Q · filed 2025-10-28 | $615.19M derived: sum of 2 quarters · filed 2025-10-28 | $915.45M 10-Q · filed 2025-10-28 | $1.20B derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-06-30 | $305.98M 10-Q · filed 2025-07-29 | $606.24M 10-Q · filed 2025-07-29 | $894.47M derived: sum of 3 quarters · filed 2026-02-10 | $1.16B derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2024-03-31 | $300.26M 10-Q · filed 2025-04-29 | $588.49M derived: sum of 2 quarters · filed 2026-02-10 | $856.38M derived: sum of 3 quarters · filed 2026-02-10 | $1.14B derived: sum of 4 quarters · filed 2026-02-10 | ||||
| 2023-12-31 | $288.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $556.13M derived: sum of 2 quarters · filed 2026-02-10 | $840.06M derived: sum of 3 quarters · filed 2026-02-10 | $1.16B 10-K · filed 2026-02-10 | $1.16B 10-K · filed 2024-02-13 | |||
| 2023-09-30 | $267.89M 10-Q · filed 2024-10-29 | $551.82M derived: sum of 2 quarters · filed 2024-10-29 | $867.43M 10-Q · filed 2024-10-29 | $1.14B derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-06-30 | $283.93M 10-Q · filed 2024-07-30 | $599.53M 10-Q · filed 2024-07-30 | $872.35M derived: sum of 3 quarters · filed 2025-02-10 | $1.14B derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-03-31 | $315.61M 10-Q · filed 2024-04-30 | $588.42M derived: sum of 2 quarters · filed 2025-02-10 | $854.88M derived: sum of 3 quarters · filed 2025-02-10 | $1.11B derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2022-12-31 | $272.82M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $539.28M derived: sum of 2 quarters · filed 2025-02-10 | $792.56M derived: sum of 3 quarters · filed 2025-02-10 | $1.00B 10-K · filed 2025-02-10 | ||||
| 2022-09-30 | $266.46M 10-Q · filed 2023-10-31 | $519.74M derived: sum of 2 quarters · filed 2023-10-31 | $729.32M 10-Q · filed 2023-10-31 | $955.52M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-06-30 | $253.28M 10-Q · filed 2023-08-01 | $462.86M 10-Q · filed 2023-08-01 | $689.06M derived: sum of 3 quarters · filed 2024-02-13 | $879.77M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2022-03-31 | $209.58M 10-Q · filed 2023-05-02 | $435.79M derived: sum of 2 quarters · filed 2024-02-13 | $626.49M derived: sum of 3 quarters · filed 2024-02-13 | $795.35M derived: sum of 4 quarters · filed 2024-02-13 | ||||
| 2021-12-31 | $226.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $416.91M derived: sum of 2 quarters · filed 2024-02-13 | $585.76M derived: sum of 3 quarters · filed 2024-02-13 | $739.56M 10-K · filed 2024-02-13 | ||||
| 2021-09-30 | $190.70M 10-Q · filed 2022-11-01 | $359.56M derived: sum of 2 quarters · filed 2022-11-01 | $513.36M 10-Q · filed 2022-11-01 | $680.35M derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-06-30 | $168.86M 10-Q · filed 2022-08-02 | $322.65M 10-Q · filed 2022-08-02 | $489.64M derived: sum of 3 quarters · filed 2023-02-07 | $610.43M derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2021-03-31 | $153.79M 10-Q · filed 2022-05-03 | $320.78M derived: sum of 2 quarters · filed 2023-02-07 | $441.57M derived: sum of 3 quarters · filed 2023-02-07 | $559.57M derived: sum of 4 quarters · filed 2023-02-07 | ||||
| 2020-12-31 | $166.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $287.78M derived: sum of 2 quarters · filed 2023-02-07 | $405.77M derived: sum of 3 quarters · filed 2023-02-07 | $516.92M 10-K · filed 2023-02-07 | ||||
| 2020-09-30 | $120.79M 10-Q · filed 2021-11-02 | $238.79M derived: sum of 2 quarters · filed 2021-11-02 | $349.93M 10-Q · filed 2021-11-02 | $486.11M derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-06-30 | $118.00M 10-Q · filed 2021-08-03 | $229.15M 10-Q · filed 2021-08-03 | $365.32M derived: sum of 3 quarters · filed 2022-02-08 | $467.93M derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2020-03-31 | $111.15M 10-Q · filed 2021-05-04 | $247.32M derived: sum of 2 quarters · filed 2022-02-08 | $349.93M derived: sum of 3 quarters · filed 2022-02-08 | $455.88M derived: sum of 4 quarters · filed 2022-02-08 | ||||
| 2019-12-31 | $136.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $238.78M derived: sum of 2 quarters · filed 2022-02-08 | $344.73M derived: sum of 3 quarters · filed 2022-02-08 | $468.71M 10-K · filed 2022-02-08 | ||||
| 2019-09-30 | $102.61M 10-Q · filed 2020-11-05 | $208.55M derived: sum of 2 quarters · filed 2020-11-05 | $332.53M 10-Q · filed 2020-11-05 | $440.89M derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-06-30 | $105.94M 10-Q · filed 2020-08-04 | $229.93M 10-Q · filed 2020-08-04 | $338.28M derived: sum of 3 quarters · filed 2021-02-09 | $434.81M derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-03-31 | $123.98M 10-Q · filed 2020-05-05 | $232.34M derived: sum of 2 quarters · filed 2021-02-09 | $328.86M derived: sum of 3 quarters · filed 2021-02-09 | $436.89M derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2018-12-31 | $108.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $204.88M derived: sum of 2 quarters · filed 2021-02-09 | $312.91M derived: sum of 3 quarters · filed 2021-02-09 | $434.41M 10-K · filed 2021-02-09 | ||||
| 2018-09-30 | $96.52M 10-Q · filed 2019-10-29 | $204.55M derived: sum of 2 quarters · filed 2019-10-29 | $326.05M 10-Q · filed 2019-10-29 | $423.77M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $108.03M 10-Q · filed 2019-07-30 | $229.53M 10-Q · filed 2019-07-30 | $327.25M derived: sum of 3 quarters · filed 2020-02-13 | $418.52M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $121.50M 10-Q · filed 2019-04-30 | $219.22M derived: sum of 2 quarters · filed 2020-02-13 | $310.49M derived: sum of 3 quarters · filed 2020-02-13 | $400.56M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $97.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $188.99M derived: sum of 2 quarters · filed 2020-02-13 | $279.06M derived: sum of 3 quarters · filed 2020-02-13 | $366.29M 10-K · filed 2020-02-13 | $366.41M 10-K · filed 2018-02-15 | |||
| 2017-09-30 | $91.27M 10-Q · filed 2018-10-30 | $91.27M 10-Q · filed 2017-10-31 | $181.33M derived: sum of 2 quarters · filed 2018-10-30 | $268.56M 10-Q · filed 2018-10-30 | $268.58M 10-Q · filed 2017-10-31 | $364.64M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-06-30 | $90.07M 10-Q · filed 2018-07-31 | $90.07M 10-Q · filed 2017-08-01 | $177.29M 10-Q · filed 2018-07-31 | $177.31M 10-Q · filed 2017-08-01 | $273.38M derived: sum of 3 quarters · filed 2019-02-14 | $349.16M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-03-31 | $87.23M 10-Q · filed 2018-05-01 | $87.23M 10-Q · filed 2017-05-04 | $183.31M derived: sum of 2 quarters · filed 2019-02-14 | $259.09M derived: sum of 3 quarters · filed 2019-02-14 | $325.88M derived: sum of 4 quarters · filed 2019-02-14 | |||
| 2016-12-31 | $96.08M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $171.86M derived: sum of 2 quarters · filed 2019-02-14 | $238.65M derived: sum of 3 quarters · filed 2019-02-14 | $303.25M 10-K · filed 2019-02-14 | ||||
| 2016-09-30 | $75.78M 10-Q · filed 2017-10-31 | $142.57M derived: sum of 2 quarters · filed 2017-10-31 | $207.17M 10-Q · filed 2017-10-31 | $259.63M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $66.79M 10-Q · filed 2017-08-01 | $131.39M 10-Q · filed 2017-08-01 | $183.85M derived: sum of 3 quarters · filed 2018-02-15 | $231.45M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | $64.60M 10-Q · filed 2017-05-04 | $117.06M derived: sum of 2 quarters · filed 2018-02-15 | $164.66M derived: sum of 3 quarters · filed 2018-02-15 | $216.34M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | $52.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $100.07M derived: sum of 2 quarters · filed 2018-02-15 | $151.75M derived: sum of 3 quarters · filed 2018-02-15 | $196.61M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | $47.60M 10-Q · filed 2016-11-01 | $99.28M derived: sum of 2 quarters · filed 2016-11-01 | $144.15M 10-Q · filed 2016-11-01 | $192.60M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-06-30 | $51.68M 10-Q · filed 2016-08-09 | $96.55M 10-Q · filed 2016-08-09 | $145.00M derived: sum of 3 quarters · filed 2017-02-14 | $184.45M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-03-31 | $44.87M 10-Q · filed 2016-05-09 | $93.32M derived: sum of 2 quarters · filed 2017-02-14 | $132.77M derived: sum of 3 quarters · filed 2017-02-14 | $173.67M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2014-12-31 | $48.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $87.90M derived: sum of 2 quarters · filed 2017-02-14 | $128.80M derived: sum of 3 quarters · filed 2017-02-14 | $165.77M 10-K · filed 2017-02-14 | ||||
| 2014-09-30 | $39.45M 10-Q · filed 2015-11-03 | $80.34M derived: sum of 2 quarters · filed 2015-11-03 | $117.32M 10-Q · filed 2015-11-03 | $155.35M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-06-30 | $40.90M 10-Q · filed 2015-08-04 | $77.87M 10-Q · filed 2015-08-04 | $115.90M derived: sum of 3 quarters · filed 2016-02-12 | $142.35M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2014-03-31 | $36.97M 10-Q · filed 2015-04-30 | $75.00M derived: sum of 2 quarters · filed 2016-02-12 | $101.45M derived: sum of 3 quarters · filed 2016-02-12 | $124.70M derived: sum of 4 quarters · filed 2016-02-12 | ||||
| 2013-12-31 | $38.03M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $64.47M derived: sum of 2 quarters · filed 2016-02-12 | $87.72M derived: sum of 3 quarters · filed 2016-02-12 | $109.98M 10-K · filed 2016-02-12 | ||||
| 2013-09-30 | $26.45M 10-Q · filed 2014-10-30 | $49.70M derived: sum of 2 quarters · filed 2014-10-30 | $71.96M 10-Q · filed 2014-10-30 | $95.69M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-06-30 | $23.25M 10-Q · filed 2014-07-31 | $45.51M 10-Q · filed 2014-07-31 | $69.24M derived: sum of 3 quarters · filed 2015-02-17 | $89.76M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2013-03-31 | $22.26M 10-Q · filed 2014-05-01 | $45.99M derived: sum of 2 quarters · filed 2015-02-17 | $66.51M derived: sum of 3 quarters · filed 2015-02-17 | $86.23M derived: sum of 4 quarters · filed 2015-02-17 | ||||
| 2012-12-31 | $23.73M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $44.25M derived: sum of 2 quarters · filed 2015-02-17 | $63.97M derived: sum of 3 quarters · filed 2015-02-17 | $85.36M 10-K · filed 2015-02-17 | ||||
| 2012-09-30 | $20.52M 10-Q · filed 2013-10-31 | $40.24M derived: sum of 2 quarters · filed 2013-10-31 | $61.63M 10-Q · filed 2013-10-31 | $82.79M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-06-30 | $19.72M 10-Q · filed 2013-08-01 | $41.12M 10-Q · filed 2013-08-01 | $62.27M derived: sum of 3 quarters · filed 2014-02-21 | $76.55M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2012-03-31 | $21.40M 10-Q · filed 2013-05-02 | $42.55M derived: sum of 2 quarters · filed 2014-02-21 | $56.83M derived: sum of 3 quarters · filed 2014-02-21 | $68.69M derived: sum of 4 quarters · filed 2014-02-21 | ||||
| 2011-12-31 | $21.15M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $35.43M derived: sum of 2 quarters · filed 2014-02-21 | $47.29M derived: sum of 3 quarters · filed 2014-02-21 | $58.22M 10-K · filed 2014-02-21 | ||||
| 2011-09-30 | $14.28M 10-Q · filed 2012-11-01 | $26.14M derived: sum of 2 quarters · filed 2012-11-01 | $37.07M 10-Q · filed 2012-11-01 | $47.73M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $11.86M 10-Q · filed 2012-08-03 | $22.68M 10-Q · filed 2012-08-03 | $33.45M derived: sum of 3 quarters · filed 2013-02-21 | $41.91M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $10.82M 10-Q · filed 2012-04-26 | $21.59M derived: sum of 2 quarters · filed 2013-02-21 | $30.05M derived: sum of 3 quarters · filed 2013-02-21 | $37.53M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $10.77M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $19.22M derived: sum of 2 quarters · filed 2013-02-21 | $26.71M derived: sum of 3 quarters · filed 2013-02-21 | $32.33M 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | $8.46M 10-Q · filed 2011-10-27 | $15.94M derived: sum of 2 quarters · filed 2011-10-27 | $21.56M 10-Q · filed 2011-10-27 | |||||
| 2010-06-30 | $7.49M 10-Q · filed 2011-07-28 | $13.28M 10-Q · filed 2011-07-28 | ||||||
| 2010-03-31 | $5.79M 10-Q · filed 2011-05-03 | |||||||
| 2009-12-31 | $27.58M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |